Sepsis is a common disease caused mainly by bacteria that affect approximately 30 million people each year worldwide. If it is not diagnosed in time and treated properly, it can be lethal in 30% of cases. Another issue is that if it is not detected in the first 24 hours, the cost to the health care system can increase considerably.
Current diagnostic techniques are too slow and have very limited detection efficiency. Therefore, Moirai Biodesign has designed KlotoDx, a fast, efficient and cost-effective platform for early detection that allows the characterization of sepsis-related bacteria. This Will improve the treatment of the patient, avoid the side effects of broad-spectrum antibiotics and drastically reduce mortality rates.
